GSTM3
Basic information
Region (hg38): 1:109733932-109741038
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 0 |
Variants in GSTM3
This is a list of pathogenic ClinVar variants found in the GSTM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-109737169-C-G | not specified | Uncertain significance (Mar 31, 2023) | ||
1-109737469-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
1-109737702-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
1-109737748-T-G | not specified | Uncertain significance (Jan 31, 2024) | ||
1-109738119-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
1-109738128-C-T | not specified | Uncertain significance (May 26, 2024) | ||
1-109738303-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
1-109738312-G-A | not specified | Uncertain significance (Jan 25, 2023) | ||
1-109739834-T-A | not specified | Uncertain significance (Jan 10, 2023) | ||
1-109740268-A-G | not specified | Uncertain significance (Dec 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSTM3 | protein_coding | protein_coding | ENST00000540225 | 8 | 7831 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.36e-7 | 0.620 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.936 | 99 | 129 | 0.768 | 0.00000678 | 1488 |
Missense in Polyphen | 17 | 36.003 | 0.47218 | 408 | ||
Synonymous | -0.173 | 48 | 46.5 | 1.03 | 0.00000227 | 385 |
Loss of Function | 1.04 | 12 | 16.6 | 0.724 | 9.35e-7 | 172 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. May govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers. {ECO:0000269|PubMed:10587441}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Exercise-induced Circadian Regulation;Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;glutathione-mediated detoxification;Biological oxidations;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.346
Intolerance Scores
- loftool
- 0.827
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.28
Haploinsufficiency Scores
- pHI
- 0.344
- hipred
- N
- hipred_score
- 0.248
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.784
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gstm5
- Phenotype
Gene ontology
- Biological process
- glutathione metabolic process;establishment of blood-nerve barrier;nitrobenzene metabolic process;xenobiotic catabolic process;response to estrogen;cellular detoxification of nitrogen compound;glutathione derivative biosynthetic process
- Cellular component
- nucleus;cytoplasm;cytosol;sperm fibrous sheath;intercellular bridge;extracellular exosome
- Molecular function
- glutathione transferase activity;protein binding;enzyme binding;identical protein binding;protein homodimerization activity;glutathione binding